Abstract
Patients at risk of sudden cardiac death (SCD) after myocardial infarction (MI) can be offered therapy with implantable cardioverter defibrillators (ICDs). Whether plasma biomarkers can help risk stratify for SCD and ventricular arrhythmias (VT/VF) is unclear.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1344-1350 |
| Numero di pagine | 7 |
| Rivista | European Heart Journal |
| Volume | 33 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Aged
- Biological Markers
- C-Reactive Protein
- Death, Sudden, Cardiac
- Defibrillators, Implantable
- Epidemiologic Methods
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
- Tachycardia, Ventricular
Fingerprint
Entra nei temi di ricerca di 'Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the CAMI-GUIDE study'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver